SURMOUNT-1 (NCT04184622) Study Title: "Tirzepatide Once Weekly for the Treatment of Obesity" Status: Completed Phase: Phase 3 Enrollment: 2,539 participants Study Period: 2019-2021 Location: Multi-national, 119 sites Design: Randomized, double-blind, placebo-controlled Duration: 72 weeks Intervention: Tirzepatide 5/10/15 mg SC weekly vs
446 These inhibitors, such as geldanamycin, bind to the N-terminal nucleotide-binding pocket of HSP90 with higher affinity than ATP, leading to the proteasomal degradation of HSP90-dependent client proteins
There is no single correct amount more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately
Arch Biochem Biophys 595:1924 Taetzsch T, Levesque S, McGraw C, Brookins S, Luqa R, Bonini MG, Mason RP, Oh U et al (2015) Redox regulation of NF-B p50 and M1 polarization in microglia